Similar articles

• Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.

  Tada T, Byrne RA, Simunovic I, King LA, Cassese S, Joner M, Fusaro M, Schneider S, Schulz S, Ibrahim T, Ott I, Massberg S, Laugwitz KL, Kastrati A. Tada T, et al. JACC Cardiovasc Interv. 2013 Dec;6(12):1267-74. doi: 10.1016/j.jcin.2013.06.015. JACC Cardiovasc Interv. 2013. PMID: 24355117
• Coronary stent thrombosis in patients with chronic kidney disease: balancing anti-ischemic efficacy and hemorrhagic risk.

  Belardi JA, Albertal M. Belardi JA, et al. Catheter Cardiovasc Interv. 2012 Sep 1;80(3):368-9. doi: 10.1002/ccd.24568. Catheter Cardiovasc Interv. 2012. PMID: 22933347 No abstract available.
• Meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with aspiration thrombectomy Vs. Conventional percutaneous coronary intervention during ST-segment elevation myocardial infarction.

  Dominguez AC, Bittl JA, El-Hayek G, Contreras E, Tamis-Holland JE. Dominguez AC, et al. Catheter Cardiovasc Interv. 2016 Jun;87(7):1203-10. doi: 10.1002/ccd.26352. Epub 2015 Dec 23. Catheter Cardiovasc Interv. 2016. PMID: 26699698 Review.
• Intra-procedural stent thrombosis: a new risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndromes.

  Brener SJ, Cristea E, Kirtane AJ, McEntegart MB, Xu K, Mehran R, Stone GW. Brener SJ, et al. JACC Cardiovasc Interv. 2013 Jan;6(1):36-43. doi: 10.1016/j.jcin.2012.08.018. Epub 2012 Dec 19. JACC Cardiovasc Interv. 2013. PMID: 23266233
• Prevention of stent thrombosis: challenges and solutions.

  Reejhsinghani R, Lotfi AS. Reejhsinghani R, et al. Vasc Health Risk Manag. 2015 Jan 27;11:93-106. doi: 10.2147/VHRM.S43357. eCollection 2015. Vasc Health Risk Manag. 2015. PMID: 25657588 Free PMC article. Review.